Tapewire

Nasdaq · USD

MYGN

MYRIAD GENETICS INC

Export transactions ↓
Tapewire entity
5953
SEC CIK
0000899923
Parsed reports
611

Last 12 months

Inside the activity.

5 purchase rows · 1 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202630
Mar 202610
Apr 202600
May 202610
Jun 202601
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 30, 2017 Filed Oct 3, 2017 20:40 UTC
Riggsbee Richard BryanChief Financial Officer
Disposition to issuerCommon Stock 5,599 $36.18 $202,571.82
Disclosure

SEC source: 0001621899-17-000004 · edgardoc.xml · nonDerivative · entry 2

Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 113,510

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person.

Read SEC document
September 30, 2017 Filed Oct 3, 2017 20:40 UTC
Riggsbee Richard BryanChief Financial Officer
Disposition to issuerCommon Stock 7,043 $36.18 $254,815.74
Disclosure

SEC source: 0001621899-17-000004 · edgardoc.xml · nonDerivative · entry 1

Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 119,109

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person.

Read SEC document
September 30, 2017 Filed Oct 3, 2017 20:34 UTC
MARSH RICHARD ME.V.P., General Counsel
Disposition to issuerCommon Stock 5,291 $36.18 $191,428.38
Disclosure

SEC source: 0001206386-17-000008 · edgardoc.xml · nonDerivative · entry 2

MARSH RICHARD M · CIK 0001206386 · E.V.P., General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 137,885

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person.

Read SEC document
September 30, 2017 Filed Oct 3, 2017 20:34 UTC
MARSH RICHARD ME.V.P., General Counsel
Disposition to issuerCommon Stock 5,869 $36.18 $212,340.42
Disclosure

SEC source: 0001206386-17-000008 · edgardoc.xml · nonDerivative · entry 1

MARSH RICHARD M · CIK 0001206386 · E.V.P., General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 143,176

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person.

Read SEC document
September 30, 2017 Filed Oct 3, 2017 20:31 UTC
LANCHBURY JERRY SChief Scientific Officer
Disposition to issuerCommon Stock 5,459 $36.18 $197,506.62
Disclosure

SEC source: 0001219036-17-000006 · edgardoc.xml · nonDerivative · entry 2

LANCHBURY JERRY S · CIK 0001219036 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 138,809

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person.

Read SEC document
September 30, 2017 Filed Oct 3, 2017 20:31 UTC
LANCHBURY JERRY SChief Scientific Officer
Disposition to issuerCommon Stock 5,869 $36.18 $212,340.42
Disclosure

SEC source: 0001219036-17-000006 · edgardoc.xml · nonDerivative · entry 1

LANCHBURY JERRY S · CIK 0001219036 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 144,268

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person.

Read SEC document
September 17, 2017 Filed Sep 19, 2017 21:50 UTC
King Gary A.Exec. VP International Ops
Disposition to issuerCommon Stock 5,400 $33.05 $178,470.00
Disclosure

SEC source: 0001495800-17-000004 · edgardoc.xml · nonDerivative · entry 1

King Gary A. · CIK 0001495800 · Exec. VP International Ops

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 129,489

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person.

Read SEC document
September 17, 2017 Filed Sep 19, 2017 21:48 UTC
Ford AlexanderPresident, MGL
Disposition to issuerCommon Stock 1,937 $33.05 $64,017.85
Disclosure

SEC source: 0001644335-17-000004 · edgardoc.xml · nonDerivative · entry 1

Ford Alexander · CIK 0001644335 · President, MGL

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,780

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person.

Read SEC document
September 17, 2017 Filed Sep 19, 2017 21:45 UTC
McDade Ralph LPresident Myriad RBM, Inc.
Disposition to issuerCommon Stock 2,188 $33.05 $72,313.40
Disclosure

SEC source: 0001594674-17-000004 · edgardoc.xml · nonDerivative · entry 1

McDade Ralph L · CIK 0001594674 · President Myriad RBM, Inc.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 111,877

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person.

Read SEC document
September 17, 2017 Filed Sep 19, 2017 21:28 UTC
LANCHBURY JERRY SChief Scientific Officer
Disposition to issuerCommon Stock 6,897 $33.05 $227,945.85
Disclosure

SEC source: 0001219036-17-000004 · edgardoc.xml · nonDerivative · entry 1

LANCHBURY JERRY S · CIK 0001219036 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,137

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person.

Read SEC document
September 17, 2017 Filed Sep 19, 2017 21:24 UTC
MARSH RICHARD ME.V.P., General Counsel
Disposition to issuerCommon Stock 6,684 $33.05 $220,906.20
Disclosure

SEC source: 0001206386-17-000006 · edgardoc.xml · nonDerivative · entry 1

MARSH RICHARD M · CIK 0001206386 · E.V.P., General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 149,045

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person.

Read SEC document
September 17, 2017 Filed Sep 19, 2017 21:20 UTC
Capone Mark ChristopherPresident & C.E.O.
Disposition to issuerCommon Stock 11,671 $33.05 $385,726.55
Disclosure

SEC source: 0001352413-17-000004 · edgardoc.xml · nonDerivative · entry 1

Capone Mark Christopher · CIK 0001352413 · President & C.E.O.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 360,780

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person.

Read SEC document
September 13, 2017 Filed Sep 15, 2017 21:05 UTC
King Gary A.Exec. VP International Ops
GrantCommon Stock 30,000 $0.00 $0.00
Disclosure

SEC source: 0001495800-17-000002 · edgardoc.xml · nonDerivative · entry 1

King Gary A. · CIK 0001495800 · Exec. VP International Ops

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 134,889

F1 · kind: Consists of restricted stock units granted pursuant to the Company's 2010 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 25% on September 25, 2018, 25% on September 25, 2019, 25% on September 25, 2020, and 25% on September 25, 2021.

Read SEC document
September 13, 2017 Filed Sep 15, 2017 20:58 UTC
Verratti MarkPresident Assurex Health Inc.
GrantCommon Stock 40,000 $0.00 $0.00
Disclosure

SEC source: 0001517026-17-000007 · edgardoc.xml · nonDerivative · entry 1

Verratti Mark · CIK 0001517026 · President Assurex Health Inc.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

F1 · kind: Consists of restricted stock units granted pursuant to the Company's 2010 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 25% on September 25, 2018, 25% on September 25, 2019, 25% on September 25, 2020, and 25% on September 25, 2021.

Read SEC document
September 13, 2017 Filed Sep 15, 2017 20:52 UTC
LANCHBURY JERRY SChief Scientific Officer
GrantCommon Stock 50,000 $0.00 $0.00
Disclosure

SEC source: 0001219036-17-000002 · edgardoc.xml · nonDerivative · entry 1

LANCHBURY JERRY S · CIK 0001219036 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 157,034

F1 · kind: Consists of performance stock units granted pursuant to the Company?s 2010 Employee, Director and Consultant Equity Incentive Plan. Performance stock units initially granted on September 14, 2016, subject to accomplishment of pre-determined financial performance requirements. On September 13, 2017, the Compensation Committee determined the final award amount based on the accomplishment of the applicable financial performance requirements. Each performance stock unit represents a contingent right to receive one share of the Company?s common stock,and vests 25% on September 30, 2017, 25% on September 30, 2018, 25% on September 30, 2019, and 25% on September 30, 2020.

Read SEC document
September 13, 2017 Filed Sep 15, 2017 20:46 UTC
Tobin BernardPresident Crescendo BioScience
GrantCommon Stock 40,000 $0.00 $0.00
Disclosure

SEC source: 0001628656-17-000004 · edgardoc.xml · nonDerivative · entry 1

Tobin Bernard · CIK 0001628656 · President Crescendo BioScience

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 157,862

F1 · kind: Consists of restricted stock units granted pursuant to the Company's 2010 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 25% on September 25, 2018, 25% on September 25, 2019, 25% on September 25, 2020, and 25% on September 25, 2021.

Read SEC document
September 13, 2017 Filed Sep 15, 2017 20:44 UTC
Ford AlexanderPresident, MGL
GrantCommon Stock 60,000 $0.00 $0.00
Disclosure

SEC source: 0001644335-17-000002 · edgardoc.xml · nonDerivative · entry 1

Ford Alexander · CIK 0001644335 · President, MGL

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,717

F1 · kind: Consists of performance stock units granted pursuant to the Company?s 2010 Employee, Director and Consultant Equity Incentive Plan. Performance stock units initially granted on September 14, 2016, subject to accomplishment of pre-determined financial performance requirements. On September 13, 2017, the Compensation Committee determined the final award amount based on the accomplishment of the applicable financial performance requirements. Each performance stock unit represents a contingent right to receive one share of the Company?s common stock,and vests 25% on September 30, 2017, 25% on September 30, 2018, 25% on September 30, 2019, and 25% on September 30, 2020.

Read SEC document
September 13, 2017 Filed Sep 15, 2017 20:41 UTC
McDade Ralph LPresident Myriad RBM, Inc.
GrantCommon Stock 30,000 $0.00 $0.00
Disclosure

SEC source: 0001594674-17-000002 · edgardoc.xml · nonDerivative · entry 1

McDade Ralph L · CIK 0001594674 · President Myriad RBM, Inc.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 114,065

F1 · kind: Consists of restricted stock units granted pursuant to the Company's 2010 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 25% on September 25, 2018, 25% on September 25, 2019, 25% on September 25, 2020, and 25% on September 25, 2021.

Read SEC document
September 13, 2017 Filed Sep 15, 2017 20:32 UTC
MARSH RICHARD ME.V.P., General Counsel
GrantCommon Stock 50,000 $0.00 $0.00
Disclosure

SEC source: 0001206386-17-000004 · edgardoc.xml · nonDerivative · entry 1

MARSH RICHARD M · CIK 0001206386 · E.V.P., General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 155,729

F1 · kind: Consists of performance stock units granted pursuant to the Company?s 2010 Employee, Director and Consultant Equity Incentive Plan. Performance stock units initially granted on September 14, 2016, subject to accomplishment of pre-determined financial performance requirements. On September 13, 2017, the Compensation Committee determined the final award amount based on the accomplishment of the applicable financial performance requirements. Each performance stock unit represents a contingent right to receive one share of the Company?s common stock,and vests 25% on September 30, 2017, 25% on September 30, 2018, 25% on September 30, 2019, and 25% on September 30, 2020.

Read SEC document
September 13, 2017 Filed Sep 15, 2017 20:39 UTC
Riggsbee Richard BryanChief Financial Officer
GrantCommon Stock 60,000 $0.00 $0.00
Disclosure

SEC source: 0001621899-17-000002 · edgardoc.xml · nonDerivative · entry 1

Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 126,152

F1 · kind: Consists of performance stock units granted pursuant to the Company?s 2010 Employee, Director and Consultant Equity Incentive Plan. Performance stock units initially granted on September 14, 2016, subject to accomplishment of pre-determined financial performance requirements. On September 13, 2017, the Compensation Committee determined the final award amount based on the accomplishment of the applicable financial performance requirements. Each performance stock unit represents a contingent right to receive one share of the Company?s common stock,and vests 25% on September 30, 2017, 25% on September 30, 2018, 25% on September 30, 2019, and 25% on September 30, 2020.

Read SEC document
September 13, 2017 Filed Sep 15, 2017 20:31 UTC
Capone Mark ChristopherPresident & C.E.O.
GrantCommon Stock 165,000 $0.00 $0.00
Disclosure

SEC source: 0001352413-17-000002 · edgardoc.xml · nonDerivative · entry 1

Capone Mark Christopher · CIK 0001352413 · President & C.E.O.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 372,451

F1 · kind: Consists of performance stock units granted pursuant to the Company?s 2010 Employee, Director and Consultant Equity Incentive Plan. Performance stock units initially granted on September 14, 2016, subject to accomplishment of pre-determined financial performance requirements. On September 13, 2017, the Compensation Committee determined the final award amount based on the accomplishment of the applicable financial performance requirements. Each performance stock unit represents a contingent right to receive one share of the Company?s common stock,and vests 25% on September 30, 2017, 25% on September 30, 2018, 25% on September 30, 2019, and 25% on September 30, 2020.

Read SEC document
September 01, 2017 Filed Sep 5, 2017 18:08 UTC Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 10,000 $0.00 Strike: $16.46 $0.00
Disclosure

SEC source: 0001226488-17-000005 · edgardoc.xml · derivative · entry 10

HENDERSON JOHN T · CIK 0001226488 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2017-11-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2 · derivative.exercise_date: Options vest in full upon completion of one full year of service, generally on the earlier of the first anniversary of the date of grant or the date of the next annual meeting of stockholders.

Read SEC document
September 01, 2017 Filed Sep 5, 2017 18:08 UTC Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 10,000 $0.00 Strike: $16.46 $0.00
Disclosure

SEC source: 0001226488-17-000005 · edgardoc.xml · derivative · entry 9

HENDERSON JOHN T · CIK 0001226488 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2017-11-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2 · derivative.exercise_date: Options vest in full upon completion of one full year of service, generally on the earlier of the first anniversary of the date of grant or the date of the next annual meeting of stockholders.

Read SEC document
September 01, 2017 Filed Sep 5, 2017 18:08 UTC Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 10,000 $0.00 Strike: $16.46 $0.00
Disclosure

SEC source: 0001226488-17-000005 · edgardoc.xml · derivative · entry 8

HENDERSON JOHN T · CIK 0001226488 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 10,000 shares

Expires 2017-11-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2 · derivative.exercise_date: Options vest in full upon completion of one full year of service, generally on the earlier of the first anniversary of the date of grant or the date of the next annual meeting of stockholders.

Read SEC document
September 01, 2017 Filed Sep 5, 2017 18:08 UTC SaleCommon Stock 10,000 $30.30 $302,981.00
Disclosure

SEC source: 0001226488-17-000005 · edgardoc.xml · nonDerivative · entry 6

HENDERSON JOHN T · CIK 0001226488 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,524

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
September 01, 2017 Filed Sep 5, 2017 18:08 UTC Exercise / conversionCommon Stock 10,000 $16.46 $164,600.00
Disclosure

SEC source: 0001226488-17-000005 · edgardoc.xml · nonDerivative · entry 5

HENDERSON JOHN T · CIK 0001226488 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,524

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
September 01, 2017 Filed Sep 5, 2017 18:08 UTC SaleCommon Stock 10,000 $30.30 $303,003.00
Disclosure

SEC source: 0001226488-17-000005 · edgardoc.xml · nonDerivative · entry 4

HENDERSON JOHN T · CIK 0001226488 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,524

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
September 01, 2017 Filed Sep 5, 2017 18:08 UTC Exercise / conversionCommon Stock 10,000 $16.46 $164,600.00
Disclosure

SEC source: 0001226488-17-000005 · edgardoc.xml · nonDerivative · entry 3

HENDERSON JOHN T · CIK 0001226488 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,524

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
September 01, 2017 Filed Sep 5, 2017 18:08 UTC SaleCommon Stock 10,000 $30.31 $303,056.00
Disclosure

SEC source: 0001226488-17-000005 · edgardoc.xml · nonDerivative · entry 2

HENDERSON JOHN T · CIK 0001226488 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,524

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
September 01, 2017 Filed Sep 5, 2017 18:08 UTC Exercise / conversionCommon Stock 10,000 $16.46 $164,600.00
Disclosure

SEC source: 0001226488-17-000005 · edgardoc.xml · nonDerivative · entry 1

HENDERSON JOHN T · CIK 0001226488 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,524

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
June 22, 2017 Filed Jul 17, 2017 20:27 UTC
MARSH RICHARD ME.V.P., General Counsel
GiftCommon Stock 5,555 $0.00 $0.00
Disclosure

SEC source: 0001206386-17-000002 · edgardoc.xml · nonDerivative · entry 1

MARSH RICHARD M · CIK 0001206386 · E.V.P., General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 105,729

Read SEC document
February 23, 2017 Filed Feb 23, 2017 16:20 UTC PurchaseCommon Stock 400 $18.57 $7,429.20
Disclosure

SEC source: 0001226488-17-000002 · edgardoc.xml · nonDerivative · entry 3

HENDERSON JOHN T · CIK 0001226488 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,524

Read SEC document
February 23, 2017 Filed Feb 23, 2017 16:20 UTC PurchaseCommon Stock 3,600 $18.58 $66,888.00
Disclosure

SEC source: 0001226488-17-000002 · edgardoc.xml · nonDerivative · entry 2

HENDERSON JOHN T · CIK 0001226488 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,124

Read SEC document
February 22, 2017 Filed Feb 23, 2017 16:20 UTC PurchaseCommon Stock 2,000 $18.81 $37,613.00
Disclosure

SEC source: 0001226488-17-000002 · edgardoc.xml · nonDerivative · entry 1

HENDERSON JOHN T · CIK 0001226488 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,524

Read SEC document
January 03, 2017 Filed Jan 4, 2017 18:22 UTC
Tobin BernardPresident Crescendo BioScience
Disposition to issuerCommon Stock 2,631 $16.93 $44,542.83
Disclosure

SEC source: 0001628656-17-000002 · edgardoc.xml · nonDerivative · entry 1

Tobin Bernard · CIK 0001628656 · President Crescendo BioScience

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 116,360

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person.

Read SEC document
December 01, 2016 Filed Dec 2, 2016 00:26 UTC GrantCommon Stock 15,024 $0.00 $0.00
Disclosure

SEC source: 0001471518-16-000007 · edgardoc.xml · nonDerivative · entry 1

Phanstiel S. Louise · CIK 0001471518 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,524

F1 · kind: Consists of restricted stock units granted pursuant to the Company's 2010 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests on the anniversary of the date of grant.

Read SEC document
December 01, 2016 Filed Dec 2, 2016 00:16 UTC GrantCommon Stock 15,024 $0.00 $0.00
Disclosure

SEC source: 0001226488-16-000006 · edgardoc.xml · nonDerivative · entry 1

HENDERSON JOHN T · CIK 0001226488 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,524

F1 · kind: Consists of restricted stock units granted pursuant to the Company's 2010 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests on the anniversary of the date of grant.

Read SEC document
December 01, 2016 Filed Dec 2, 2016 00:21 UTC GrantCommon Stock 15,024 $0.00 $0.00
Disclosure

SEC source: 0001274225-16-000004 · edgardoc.xml · nonDerivative · entry 1

LANGER DENNIS · CIK 0001274225 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,524

F1 · kind: Consists of restricted stock units granted pursuant to the Company's 2010 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests on the anniversary of the date of grant.

Read SEC document
December 01, 2016 Filed Dec 2, 2016 00:10 UTC GrantCommon Stock 15,024 $0.00 $0.00
Disclosure

SEC source: 0001379372-16-000006 · edgardoc.xml · nonDerivative · entry 1

DREISMANN HEINRICH · CIK 0001471714 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,524

F1 · kind: Consists of restricted stock units granted pursuant to the Company's 2010 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests on the anniversary of the date of grant.

Read SEC document
December 01, 2016 Filed Dec 2, 2016 00:13 UTC GrantCommon Stock 15,024 $0.00 $0.00
Disclosure

SEC source: 0001236368-16-000006 · edgardoc.xml · nonDerivative · entry 1

GILBERT WALTER PHD · CIK 0001236368 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,524

F1 · kind: Consists of restricted stock units granted pursuant to the Company's 2010 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests on the anniversary of the date of grant.

Read SEC document
December 01, 2016 Filed Dec 2, 2016 00:06 UTC GrantCommon Stock 15,024 $0.00 $0.00
Disclosure

SEC source: 0001191248-16-000004 · edgardoc.xml · nonDerivative · entry 1

BEST LAWRENCE C · CIK 0001191248 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,524

F1 · kind: Consists of restricted stock units granted pursuant to the Company's 2010 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests on the anniversary of the date of grant.

Read SEC document
October 17, 2016 Filed Oct 17, 2016 23:09 UTC
Riggsbee Richard BryanChief Financial Officer
Disposition to issuerCommon Stock 3,522 $19.31 $68,009.82
Disclosure

SEC source: 0001621899-16-000008 · edgardoc.xml · nonDerivative · entry 1

Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,152

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person.

Read SEC document
September 30, 2016 Filed Oct 3, 2016 22:08 UTC
Tobin BernardPresident Crescendo BioScience
Disposition to issuerCommon Stock 4,661 $20.58 $95,923.38
Disclosure

SEC source: 0001628656-16-000008 · edgardoc.xml · nonDerivative · entry 1

Tobin Bernard · CIK 0001628656 · President Crescendo BioScience

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 118,991

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person.

Read SEC document
September 30, 2016 Filed Oct 3, 2016 21:55 UTC
Ford AlexanderPresident, MGL
Disposition to issuerCommon Stock 1,937 $20.58 $39,863.46
Disclosure

SEC source: 0001644335-16-000012 · edgardoc.xml · nonDerivative · entry 1

Ford Alexander · CIK 0001644335 · President, MGL

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,213

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person.

Read SEC document
September 30, 2016 Filed Oct 3, 2016 21:54 UTC
LANCHBURY JERRY SChief Scientific Officer
Disposition to issuerCommon Stock 5,459 $20.58 $112,346.22
Disclosure

SEC source: 0001219036-16-000014 · edgardoc.xml · nonDerivative · entry 1

LANCHBURY JERRY S · CIK 0001219036 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 107,034

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person.

Read SEC document
September 30, 2016 Filed Oct 3, 2016 21:53 UTC
McDade Ralph LPresident Myriad RBM, Inc.
Disposition to issuerCommon Stock 1,641 $20.58 $33,771.78
Disclosure

SEC source: 0001594674-16-000019 · edgardoc.xml · nonDerivative · entry 1

McDade Ralph L · CIK 0001594674 · President Myriad RBM, Inc.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,891

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person.

Read SEC document
September 30, 2016 Filed Oct 3, 2016 21:51 UTC
Riggsbee Richard BryanChief Financial Officer
Disposition to issuerCommon Stock 5,599 $20.58 $115,227.42
Disclosure

SEC source: 0001621899-16-000006 · edgardoc.xml · nonDerivative · entry 1

Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,674

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person.

Read SEC document
September 30, 2016 Filed Oct 3, 2016 21:50 UTC
Wenstrup RichardChief Medical Officer
Disposition to issuerCommon Stock 931 $20.58 $19,159.98
Disclosure

SEC source: 0001645683-16-000012 · edgardoc.xml · nonDerivative · entry 1

Wenstrup Richard · CIK 0001645683 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,207

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person.

Read SEC document
September 30, 2016 Filed Oct 3, 2016 21:48 UTC
MARSH RICHARD ME.V.P., General Counsel
Disposition to issuerCommon Stock 3,646 $20.58 $75,034.68
Disclosure

SEC source: 0001206386-16-000020 · edgardoc.xml · nonDerivative · entry 1

MARSH RICHARD M · CIK 0001206386 · E.V.P., General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,134

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person.

Read SEC document
September 30, 2016 Filed Oct 3, 2016 21:46 UTC
King Gary A.Exec. VP International Ops
Disposition to issuerCommon Stock 4,050 $20.58 $83,349.00
Disclosure

SEC source: 0001495800-16-000022 · edgardoc.xml · nonDerivative · entry 1

King Gary A. · CIK 0001495800 · Exec. VP International Ops

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,449

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.